News
Medipal Holdings-JCR Pharmaceuticals’ JR-446 for mucopolysaccharidosis type IIIB recevies EC orphan drug designation: Tokyo Thursday, June 26, 2025, 15:00 Hrs [IST] Medipal Hold ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback